This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Agilent, Limelight: After-Hours Trading

Stocks in this article: A LLNW NDAQ MAR CLI ANIK

Nasdaq OMX

Shares of Nasdaq OMX (NDAQ - Get Report) stumbled in late trades after the trading exchange operator announced Adena Friedman is resigning from the chief financial officer post.

Friedman, who also serves as executive vice president, corporate strategy, is leaving the company to join buyout firm The Carlyle Group.



The stock was last quoted at $27.70, down 6.5%, on volume of roughly 70,000. At recent prices, the shares were up more than 50% in the past year, hitting a 52-week high of $28.22 on Friday as a wave of consolidation swept exchange operators, most notably with NYSE Euronext (NYX) agreeing to combine with Deutsche Borse.

Marriott International

Hotel operator Marriott International (MAR - Get Report) saw its shares rise more than 4% to $42.80 on extended volume of roughly 280,000 after the company beat Wall Street's expectations for its fourth-quarter earnings.

The company also disclosed plans to spin off its timeshare business, saying it expects to complete the transaction in late 2011. For the three months ended Dec. 31, Marriott reported an adjusted profit of $150 million, or 39 cents a share, besting the average estimate of analysts polled by Thomson Reuters for earnings of 36 cents a share.

Other stocks making notable moves in after-hours action included Mack-Cali Realty (CLI - Get Report), which dipped almost 5% after the Edison, N.J.-based real estate investment trust launched a public offering of 5.5 million common stock units; and Anika Therapeutics (ANIK - Get Report), whose shares dropped more than 15% after the company offered up some regulatory news, saying it's requested a review of its proposed osteoarthritis drug Monovisc by the Orthopedic Advisory Panel, among other developments.

-- Written by Michael Baron in New York.



>To contact the writer of this article, click here: Michael Baron.

>To submit a news tip, send an email to: tips@thestreet.com

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs